These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 32319535)
21. Neferine treatment enhances the TRAIL‑induced apoptosis of human prostate cancer cells via autophagic flux and the JNK pathway. Nazim UM; Yin H; Park SY Int J Oncol; 2020 May; 56(5):1152-1161. PubMed ID: 32319589 [TBL] [Abstract][Full Text] [Related]
24. Tetrandrine (TET) Induces Death Receptors Apo Trail R1 (DR4) and Apo Trail R2 (DR5) and Sensitizes Prostate Cancer Cells to TRAIL-Induced Apoptosis. Shishodia G; Koul S; Dong Q; Koul HK Mol Cancer Ther; 2018 Jun; 17(6):1217-1228. PubMed ID: 29549167 [TBL] [Abstract][Full Text] [Related]
25. CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non small-cell lung cancer cells. Chen S; Liu X; Yue P; Schönthal AH; Khuri FR; Sun SY Mol Pharmacol; 2007 Nov; 72(5):1269-79. PubMed ID: 17684158 [TBL] [Abstract][Full Text] [Related]
26. Ginsenoside compound K sensitizes human colon cancer cells to TRAIL-induced apoptosis via autophagy-dependent and -independent DR5 upregulation. Chen L; Meng Y; Sun Q; Zhang Z; Guo X; Sheng X; Tai G; Cheng H; Zhou Y Cell Death Dis; 2016 Aug; 7(8):e2334. PubMed ID: 27512955 [TBL] [Abstract][Full Text] [Related]
27. Suppression of cFLIP is sufficient to sensitize human melanoma cells to TRAIL- and CD95L-mediated apoptosis. Geserick P; Drewniok C; Hupe M; Haas TL; Diessenbacher P; Sprick MR; Schön MP; Henkler F; Gollnick H; Walczak H; Leverkus M Oncogene; 2008 May; 27(22):3211-20. PubMed ID: 18084329 [TBL] [Abstract][Full Text] [Related]
28. Snake venom toxin from Vipera lebetina turanica sensitizes cancer cells to TRAIL through ROS- and JNK-mediated upregulation of death receptors and downregulation of survival proteins. Park MH; Jo M; Won D; Song HS; Song MJ; Hong JT Apoptosis; 2012 Dec; 17(12):1316-26. PubMed ID: 23007278 [TBL] [Abstract][Full Text] [Related]
29. Farnesoid X receptor induces cell death and sensitizes to TRAIL-induced inhibition of growth in colorectal cancer cells through the up-regulation of death receptor 5. Hotta M; Sakatani T; Ishino K; Wada R; Kudo M; Yokoyama Y; Yamada T; Yoshida H; Naito Z Biochem Biophys Res Commun; 2019 Nov; 519(4):824-831. PubMed ID: 31561852 [TBL] [Abstract][Full Text] [Related]
30. Quercetin sensitizes human hepatoma cells to TRAIL-induced apoptosis via Sp1-mediated DR5 up-regulation and proteasome-mediated c-FLIPS down-regulation. Kim JY; Kim EH; Park SS; Lim JH; Kwon TK; Choi KS J Cell Biochem; 2008 Dec; 105(6):1386-98. PubMed ID: 18980244 [TBL] [Abstract][Full Text] [Related]
31. The pyrrolo-1,5-benzoxazepine, PBOX-15, enhances TRAIL‑induced apoptosis by upregulation of DR5 and downregulation of core cell survival proteins in acute lymphoblastic leukaemia cells. Nathwani SM; Greene LM; Butini S; Campiani G; Williams DC; Samali A; Szegezdi E; Zisterer DM Int J Oncol; 2016 Jul; 49(1):74-88. PubMed ID: 27176505 [TBL] [Abstract][Full Text] [Related]
32. Activation of autophagy flux by metformin downregulates cellular FLICE-like inhibitory protein and enhances TRAIL- induced apoptosis. Nazim UM; Moon JH; Lee JH; Lee YJ; Seol JW; Eo SK; Lee JH; Park SY Oncotarget; 2016 Apr; 7(17):23468-81. PubMed ID: 26992204 [TBL] [Abstract][Full Text] [Related]
33. Targeting KPNB1 overcomes TRAIL resistance by regulating DR5, Mcl-1 and FLIP in glioblastoma cells. Zhu ZC; Liu JW; Yang C; Li MJ; Wu RJ; Xiong ZQ Cell Death Dis; 2019 Feb; 10(2):118. PubMed ID: 30742128 [TBL] [Abstract][Full Text] [Related]
34. Potentiation of TRAIL‑induced cell death by nonsteroidal anti‑inflammatory drug in human hepatocellular carcinoma cells through the ER stress‑dependent autophagy pathway. Lee SH; Moon HJ; Lee YS; Kang CD; Kim SH Oncol Rep; 2020 Sep; 44(3):1136-1148. PubMed ID: 32705218 [TBL] [Abstract][Full Text] [Related]
35. Synergistic effect of TRAIL and irradiation in elimination of glioblastoma stem-like cells. Liu J; Gao Q; Xie T; Liu Y; Luo L; Xu C; Shen L; Wan F; Lei T; Ye F Clin Exp Med; 2018 Aug; 18(3):399-411. PubMed ID: 29777390 [TBL] [Abstract][Full Text] [Related]
36. Andrographolide sensitizes human renal carcinoma cells to TRAIL‑induced apoptosis through upregulation of death receptor 4. Bi R; Deng Y; Tang C; Xuan L; Xu B; Du Y; Wang C; Wei W Oncol Rep; 2020 Nov; 44(5):1939-1948. PubMed ID: 33000263 [TBL] [Abstract][Full Text] [Related]
37. Progesterone induces apoptosis in TRAIL-resistant ovarian cancer cells by circumventing c-FLIPL overexpression. Syed V; Mukherjee K; Godoy-Tundidor S; Ho SM J Cell Biochem; 2007 Oct; 102(2):442-52. PubMed ID: 17393432 [TBL] [Abstract][Full Text] [Related]
38. Metformin sensitizes human bladder cancer cells to TRAIL-induced apoptosis through mTOR/S6K1-mediated downregulation of c-FLIP. Zhang T; Wang X; He D; Jin X; Guo P Anticancer Drugs; 2014 Sep; 25(8):887-97. PubMed ID: 24714080 [TBL] [Abstract][Full Text] [Related]
39. Death receptor 5 and cellular FLICE-inhibitory protein regulate pemetrexed-induced apoptosis in human lung cancer cells. Su L; Liu G; Hao X; Zhong N; Zhong D; Liu X; Singhal S Eur J Cancer; 2011 Nov; 47(16):2471-8. PubMed ID: 21726997 [TBL] [Abstract][Full Text] [Related]
40. DR4 specific TRAIL variants are more efficacious than wild-type TRAIL in pancreatic cancer. Yu R; Albarenque SM; Cool RH; Quax WJ; Mohr A; Zwacka RM Cancer Biol Ther; 2014; 15(12):1658-66. PubMed ID: 25482930 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]